Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

AMACR antibody

AMACR Reactivity: Human IHC, StM Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN6939433
  • Target See all AMACR Antibodies
    AMACR (alpha-Methylacyl-CoA Racemase (AMACR))
    Reactivity
    • 110
    • 32
    • 29
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 77
    • 35
    • 2
    Rabbit
    Clonality
    • 64
    • 50
    Polyclonal
    Conjugate
    • 63
    • 8
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This AMACR antibody is un-conjugated
    Application
    • 88
    • 52
    • 44
    • 35
    • 17
    • 17
    • 14
    • 13
    • 7
    • 6
    • 6
    • 4
    • 3
    • 3
    • 1
    • 1
    Immunohistochemistry (IHC), Staining Methods (StM)
    Specificity
    This antibody recognizes a protein of 54 kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.
    Immunogen
    A synthetic peptide from human AMACR protein
    Isotype
    IgG
    Top Product
    Discover our top product AMACR Primary Antibody
  • Application Notes

    Positive Control: HEK cells. Prostate Adenocarcinoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1:50-1:100 for 30-60 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Expiry Date
    24 months
  • Target
    AMACR (alpha-Methylacyl-CoA Racemase (AMACR))
    Alternative Name
    AMACR (AMACR Products)
    Synonyms
    AMACR antibody, DKFZp469O1232 antibody, amacr antibody, NCU04099.1 antibody, MGC89832 antibody, AMACRD antibody, CBAS4 antibody, RACE antibody, RM antibody, Macr1 antibody, Da1-8 antibody, Marc1 antibody, alpha-methylacyl-CoA racemase antibody, PROBABLE ALPHA-METHYLACYL-COA RACEMASE MCR (2-methylacyl-CoA racemase) (2-arylpropionyl-CoA epimerase) antibody, Alpha-methylacyl-CoA racemase antibody, alpha-methylacyl-CoA racemase L homeolog antibody, AMACR antibody, mcr antibody, BPSL0064 antibody, Maqu_2037 antibody, UREG_03852 antibody, MCYG_01809 antibody, amacr antibody, amacr.L antibody, MGYG_04259 antibody, NCU04099 antibody, Amacr antibody
    Molecular Weight
    42kDa
    Gene ID
    23600
    UniProt
    Q9UHK6
    Pathways
    Monocarboxylic Acid Catabolic Process
You are here:
Support